Most Recent Articles about NVS
Pharma Stock Roundup: J&J's Mixed Q4, Roche & Novartis' New Drugs Approval in EU|stock_roundup-731626 Jan 24, 2020 - J&J (JNJ) announces mixed Q4 results. Roche's (RHHBY) lymphoma drug, Polivy and Novartis' (NVS) Mayzent for secondary progressive multiple sclerosis (SPMS) get approval in Europe.
Jazz (JAZZ) Submits NDA for Xyrem Follow-On Candidate JZP-258|company_news_-_medical_sector-730536 Jan 23, 2020 - Jazz (JAZZ) files regulatory application seeking approval for JZP-258, a low sodium formulation of Xyrem, in the United States.
STMicroelectronics NV (STM) CEO Jean-Marc on Q4 2019 Results - Earnings Call Transcript Jan 23, 2020 - STMicroelectronics NV (NYSE:STM) Q4 2019 Earnings Conference Call January 23, 2020, 03:30 ET Company Participants Celine Berthier - Group VP, IR Jean-Marc - President & CEO Lorenzo Grandi - Presid

Related Companies

Name Exchange Price Mkt Cap
MRK Merck & Company, Inc. NYSE $70.42 $187.28B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals